tiprankstipranks
Greenwich LifeSciences (GLSI)
NASDAQ:GLSI
US Market
Holding GLSI?
Track your performance easily

Greenwich LifeSciences (GLSI) Income Statement

367 Followers

Greenwich LifeSciences Income Statement

Last quarter (Q ), Greenwich LifeSciences's total revenue was $―, a decrease of ― from the same quarter last year. In Q, Greenwich LifeSciences's net income was $-2.67M. See Greenwich LifeSciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
-----$ 0.00
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 10.76M$ 9.33M$ 8.04M$ 4.60M$ 1.86M$ 3.43M
Operating Income
$ -10.76M$ -9.33M$ -8.04M$ -4.60M$ -1.86M$ -3.43M
Net Non Operating Interest Income Expense
$ 268.36K$ 436.06K$ 215.02K$ 27.37K$ 832.00-
Other Income Expense
------
Pretax Income
$ -10.50M$ -8.89M$ -7.83M$ -4.57M$ -1.86M$ -3.43M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -10.50M$ -8.89M$ -7.83M$ -4.57M$ -1.86M$ -3.43M
Basic EPS
$ -0.79$ -0.69$ -0.61$ -0.35$ -0.20$ -0.29
Diluted EPS
$ -0.79$ -0.69$ -0.61$ -0.35$ -0.20$ -0.29
Basic Average Shares
$ 51.76M$ 12.85M$ 12.91M$ 12.94M$ 9.50M$ 11.97M
Diluted Average Shares
$ 64.61M$ 12.85M$ 12.91M$ 12.94M$ 9.50M$ 11.97M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 10.76M$ 9.33M$ 8.04M$ 4.60M$ 1.86M$ 3.43M
Net Income From Continuing And Discontinued Operation
$ -10.50M$ -8.89M$ -7.83M$ -4.57M$ -1.86M$ -3.43M
Normalized Income
$ -9.84M$ -7.02M---$ -3.43M
Interest Expense
------
EBIT
$ -10.58M$ -9.33M$ -8.04M$ -4.60M$ -1.86M$ -3.43M
EBITDA
$ -10.58M$ -9.32M$ -8.04M$ -4.59M$ -1.86M$ -3.42M
Currency in USD

Greenwich LifeSciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis